KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $697.7 million.

  • Bio-Rad Laboratories' Change in Receivables rose 1037.81% to $697.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.7 billion, marking a year-over-year increase of 404.61%. This contributed to the annual value of $2.7 billion for FY2025, which is 404.61% up from last year.
  • Per Bio-Rad Laboratories' latest filing, its Change in Receivables stood at $697.7 million for Q4 2025, which was up 1037.81% from $653.8 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Change in Receivables ranged from a high of $728.6 million in Q2 2021 and a low of $627.2 million during Q2 2024
  • Its 5-year average for Change in Receivables is $674.0 million, with a median of $669.4 million in 2022.
  • As far as peak fluctuations go, Bio-Rad Laboratories' Change in Receivables soared by 3053.86% in 2021, and later plummeted by 1071.68% in 2022.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Change in Receivables stood at $709.3 million in 2021, then grew by 1.15% to $717.4 million in 2022, then decreased by 5.68% to $676.7 million in 2023, then fell by 6.59% to $632.1 million in 2024, then rose by 10.38% to $697.7 million in 2025.
  • Its Change in Receivables was $697.7 million in Q4 2025, compared to $653.8 million in Q3 2025 and $664.9 million in Q2 2025.